駿碼科技(08490.HK)延遲刊發年度業績
格隆匯3月23日丨駿碼科技(08490.HK)公佈,由於新型冠狀病毒病(COVID-19)疫情,中國內地的差旅及工作安排,以及中國內地與香港之間的差旅安排都受到了重大且前所未有的限制。因此,集團遇到了一些情況,即無法向公司核數師有效提供若干相關財務文件及其他核查文件,亦無法安排核數師進入集團在中國內地的經營場所或接觸集團在中國內地的人員以進行相關現場工作,從而完成集團截至2019年12月31日止年度的綜合財務報表的審核。董事會預期,這將不可避免地造成審核完成出現一定延遲,因此刊發及寄發集團全年業績公佈及年報的日期需相應延後。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.